NO985342L - Preparat for behandling Ún gang pr. dag av syklooksygenase-2-medierte sykdommer - Google Patents

Preparat for behandling Ún gang pr. dag av syklooksygenase-2-medierte sykdommer

Info

Publication number
NO985342L
NO985342L NO985342A NO985342A NO985342L NO 985342 L NO985342 L NO 985342L NO 985342 A NO985342 A NO 985342A NO 985342 A NO985342 A NO 985342A NO 985342 L NO985342 L NO 985342L
Authority
NO
Norway
Prior art keywords
cyclooxygenase
day
preparation
once per
mediated diseases
Prior art date
Application number
NO985342A
Other languages
English (en)
Norwegian (no)
Other versions
NO985342D0 (no
Inventor
Bruno Hancock
Conrad Winters
Barry Gertz
Elliot Ehrich
Original Assignee
Merck & Co Inc
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309472&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO985342(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612063.9A external-priority patent/GB9612063D0/en
Application filed by Merck & Co Inc, Merck Frosst Canada Inc filed Critical Merck & Co Inc
Publication of NO985342D0 publication Critical patent/NO985342D0/no
Publication of NO985342L publication Critical patent/NO985342L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO985342A 1996-05-17 1998-11-16 Preparat for behandling Ún gang pr. dag av syklooksygenase-2-medierte sykdommer NO985342L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1787896P 1996-05-17 1996-05-17
GBGB9612063.9A GB9612063D0 (en) 1996-06-10 1996-06-10 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
PCT/US1997/008041 WO1997044028A1 (en) 1996-05-17 1997-05-13 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases

Publications (2)

Publication Number Publication Date
NO985342D0 NO985342D0 (no) 1998-11-16
NO985342L true NO985342L (no) 1998-11-16

Family

ID=26309472

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985342A NO985342L (no) 1996-05-17 1998-11-16 Preparat for behandling Ún gang pr. dag av syklooksygenase-2-medierte sykdommer

Country Status (28)

Country Link
US (1) US6063811A (is)
EP (1) EP0910368A1 (is)
JP (1) JPH11512754A (is)
KR (1) KR100373622B1 (is)
CN (1) CN1140267C (is)
AR (1) AR012014A1 (is)
AU (1) AU3004997A (is)
BG (1) BG103000A (is)
BR (1) BR9709097A (is)
CA (1) CA2254061C (is)
CO (1) CO5050370A1 (is)
CZ (1) CZ291463B6 (is)
DZ (1) DZ2200A1 (is)
EA (1) EA001596B1 (is)
EE (1) EE03746B1 (is)
HR (1) HRP970262A2 (is)
HU (1) HUP9902889A3 (is)
ID (1) ID16921A (is)
IL (1) IL126899A (is)
IS (1) IS4891A (is)
MY (1) MY116201A (is)
NO (1) NO985342L (is)
NZ (1) NZ332670A (is)
PE (1) PE66998A1 (is)
PL (1) PL188649B1 (is)
SK (1) SK284330B6 (is)
TR (1) TR199802345T2 (is)
WO (1) WO1997044028A1 (is)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136804A (en) * 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
WO1999045913A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
CO5190664A1 (es) 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
CN1434713A (zh) * 1999-12-22 2003-08-06 法马西亚公司 环加氧酶－2抑制剂的缓释制剂
MXPA02012344A (es) 2000-06-13 2004-02-26 Wyeth Corp Composiciones y anti-inflamatorias que contienen inhibidores cox-2.
DK1309315T3 (da) * 2000-08-18 2006-10-09 Pharmacia Corp Hurtigt disintegrerende oral valdecoxib-formulering
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
AU2001285334A1 (en) * 2000-08-29 2002-03-13 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
AR030630A1 (es) * 2000-09-11 2003-08-27 Novartis Ag Composiciones farmaceuticas
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
US20040132780A1 (en) * 2001-05-04 2004-07-08 Allen Christopher P. Method and compositions for treating migraines
AR036312A1 (es) * 2001-08-31 2004-08-25 Novartis Ag Composicion farmaceutica
EP1429736A2 (en) * 2001-09-26 2004-06-23 Pharmacia Corporation Organoleptically acceptable intraorally disintegrating compositions
HUP0401776A2 (hu) * 2001-10-10 2004-12-28 Pharmacia Corporation Intraorálisan széteső valdekoxib készítmények porlasztásos szárítási eljárással előállítva
US20050123604A1 (en) * 2002-03-07 2005-06-09 Karnachi Anees A. Pharmaceutical compositions
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
ES2214129B1 (es) * 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 3-fenilfuran-2-onas.
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
TR200301552A1 (tr) * 2003-09-18 2005-10-21 Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. Rofekoksib' in yeni oral farmakolojik formülasyonları.
EP2114461A2 (en) * 2007-01-19 2009-11-11 Mallinckrodt Inc. Diagnostic and therapeutic cyclooxygenase-2 binding ligands
JP7291220B2 (ja) 2018-11-21 2023-06-14 トレモ― ファーマシューティカルズ，インコーポレーテッド ロフェコキシブの精製形態、製造方法および使用
US20200323813A1 (en) * 2019-04-09 2020-10-15 Tremeau Pharmaceuticals, Inc. Treatment of viral hemorrhagic fevers with cox-2 selective non-steroidal anti-inflammatory drugs
US10945992B1 (en) 2019-11-13 2021-03-16 Tremeau Pharmaceuticals, Inc. Dosage forms of rofecoxib and related methods
US11161833B1 (en) 2021-04-09 2021-11-02 Tremeau Pharmaceuticals, Inc. Deuterated etoricoxib, methods of manufacture, and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
CA2180651A1 (en) * 1994-01-10 1995-07-13 Yves Ducharme Phenyl heterocycles as cox-2 inhibitors

Also Published As

Publication number Publication date
SK156798A3 (en) 2000-01-18
AU3004997A (en) 1997-12-09
EE9800393A (et) 1999-06-15
KR20000011082A (ko) 2000-02-25
CN1140267C (zh) 2004-03-03
IL126899A (en) 2004-03-28
CA2254061A1 (en) 1997-11-27
EA001596B1 (ru) 2001-06-25
BG103000A (en) 1999-09-30
NO985342D0 (no) 1998-11-16
US6063811A (en) 2000-05-16
PL188649B1 (pl) 2005-03-31
SK284330B6 (sk) 2005-01-03
DZ2200A1 (fr) 2004-06-20
MY116201A (en) 2003-11-28
CO5050370A1 (es) 2001-06-27
JPH11512754A (ja) 1999-11-02
PE66998A1 (es) 1998-10-24
EP0910368A1 (en) 1999-04-28
TR199802345T2 (xx) 1999-03-22
HUP9902889A2 (hu) 2002-01-28
WO1997044028A1 (en) 1997-11-27
HRP970262A2 (en) 1998-06-30
HUP9902889A3 (en) 2002-04-29
EE03746B1 (et) 2002-06-17
CA2254061C (en) 2003-12-02
CZ291463B6 (cs) 2003-03-12
ID16921A (id) 1997-11-20
BR9709097A (pt) 1999-08-03
CN1225010A (zh) 1999-08-04
HK1021623A1 (en) 2000-06-23
CZ373898A3 (cs) 1999-06-16
IS4891A (is) 1998-11-10
EA199801017A1 (ru) 1999-04-29
NZ332670A (en) 2000-07-28
AR012014A1 (es) 2000-09-27
PL329940A1 (en) 1999-04-26
IL126899A0 (en) 1999-09-22
KR100373622B1 (ko) 2003-07-12

Similar Documents

Publication Publication Date Title
NO985342L (no) Preparat for behandling Ún gang pr. dag av syklooksygenase-2-medierte sykdommer
DE69734513D1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
NO951761D0 (no) Stabilt preparat for behandling av blodkoagulasjonssykdommer
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
DE69822638D1 (de) Heterocyclische vinylether zur behandlung neurologischer krankheiten
DE69509650D1 (de) Behandlung atrialer fibrillationen
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO990433D0 (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69824576D1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE69737067D1 (de) Vakzine zur behandlung von mycosen
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
NO984432L (no) FremgangsmÕte for behandling av migrenesmerte
NO961045D0 (no) Plasterpreparater for behandling av planter
NO992504L (no) Sammensetninger for behandling av jord, fremgangsmÕte for fremstilling derav, samt anvendelse
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application